Literature DB >> 27401664

Bone Marrow Suppression and Hemophagocytic Histiocytes Are Common Findings in Korean Severe Fever with Thrombocytopenia Syndrome Patients.

Sang Yong Shin1, Oh Hyun Cho2, In Gyu Bae2.   

Abstract

The causes of cytopenia in patients with severe fever with thrombocytopenia syndrome (SFTS) are not fully understood until now. We reviewed the bone marrow (BM) findings of patients with SFTS to unravel the cause of the cytopenia. Three Korean SFTS were enrolled in this study. Thrombocytopenia, neutropenia, and anemia were detected in all three patients. Severe hypocellular marrow (overall cellularity <5%) and a decreased number of megakaryocytes were noted in one patient, and hypo-/normocellular marrow and an increased number of hemophagocytic histiocytes were observed in two patients. Megakaryocytes were relatively preserved in two patients. Although a limited number of cases are available, our observations suggest that both BM suppression and peripheral destruction or sequestration are causes of cytopenia of patients with SFTS. To the best of our knowledge, this is the first well documented pathologic evaluation of Korean SFTS.

Entities:  

Keywords:  Korea; Severe fever with thrombocytopenia syndrome bunyavirus; bone marrow

Mesh:

Year:  2016        PMID: 27401664      PMCID: PMC4960399          DOI: 10.3349/ymj.2016.57.5.1286

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


INTRODUCTION

Severe fever with thrombocytopenia syndrome (SFTS) is a fatal infectious disease caused by the SFTS virus (SFTSV), which is a novel Phlebovirus in the family Bunyavirida.1 The major clinical features of patients with SFTS are high fever, thrombocytopenia, leukopenia, and gastrointestinal symptoms. Elevated serum levels of alanine aminotransferase, aspartate aminotransferase, blood urea nitrogen, lactate dehydrogenase, creatine kinase, and ferritin are also common laboratory findings in patients with SFTS. However, the pathological mechanism of thrombocytopenia and leukopenia in patients with SFTS is not fully understood until now; it is unclear whether production failure or peripheral destruction/sequestration is the main mechanism of cytopenia in these patients.234 In the present study, therefore, we investigated the bone marrow (BM) findings of patients with SFTS to understand the pathogenesis of SFTS.

CASE REPORT

Case 1

Abdominal pain developed in a 73-year-old man. He was transfused with packed red blood cells due to low hemoglobin (Hb) (7.6 g/dL) at a local hospital 10 days later. Fever, neutropenia, and elevated liver enzymes were observed. He was referred to our hospital for further evaluation and treatment. SFTSV was confirmed by reverse-transcription polymerase chain reaction (RT-PCR) analysis5 at Division of Arboviruses, National Institute of Health, Korea Centers for Disease Control and Prevention. The laboratory and clinical findings are summarized in Table 1 and 2. A BM biopsy was performed. Hemophagocytic histiocytes were observed in an aspirate (Fig. 1A), and hypocellular marrow was noted in the BM section (Fig. 1B). However, megakaryocytes were relatively preserved in the section (Fig. 1C). He was treated with antibiotics and plasmapheresis. However, he died 3 weeks after the initial symptoms (3 days after BM biopsy) due to metabolic acidosis and multi-organ failure.
Table 1

Basic Characteristics of the Patients with Severe Fever with Thrombocytopenic Syndrome (SFTS)

Case 1*Case 2*Case 3*
Age, yrs735386
SexMaleMaleFemale
Fever (℃)38.038.137.7
Organomegaly/lymphadenpathy-Inguinal lymph node-
Hemorrhage-Melena-
Central nervous system symptom/sign---
Gastro-intestinal symptom/signAbdominal pain, diarrheaAbdominal pain, melena, diarrheaDiarrhea
Clinical courseDeath (hospital day 4)Death (hospital day 10)Alive

*SFTS virus was confirmed by reverse-transcription polymerase chain reaction analysis.

Table 2

Laboratory Findings of the Patients with Severe Fever with Thrombocytopenia Syndrome

Case 1Case 2Case 3
White blood cell (×109/L) (4.0-10.0)0.761.691.14
Neutrophil (×109/L) (1.5-7.0)0.441.130.50
Hemoglobin (g/dL) (12.0-16.0)9.714.0*10.6
Platelet (×109/L) (130-400)11515121
Reticulocyte (%) (0.5-2.0)0.65-1.62
Prothrombin time (sec) (11.9-14.3)14.412.914.2
Activated partial thromboplastin time (sec) (29.1-43.5)47.946.643.6
Ferritin (ng/mL) (30.0-400.0)>2000>2000316
Fibrinogen (mg/dL) (200-450)108221200
D-dimer [fibrinogen equivalent units (FEU) ug/mL] (0-0.5)3.1619.151.22
Alanine aminotransferase (U/L) (0-41)3524923
Aspartate aminotransferase (U/L) (0-37)78111764
Lactate dehydrogenase (U/L) (135-225)740560259
Total bilirubin (mg/dL) (0-1.2)0.230.230.32
C-reactive protein (mg/L) (0-5)1.330.00.8
Erythrocyte sedimentation rate (sec) (0-9)35274
Proteinuria (-)+++
Urine blood (-)++-

*Hemoglobin was increased after transfusion of packed red blood cells.

Fig. 1

Findings of bone marrow (BM) aspirate and section of case 1 (A, B, and C), 2 (D and E), and 3 (F, G, and H). (A) The hemophagocytic histiocytes were increased in the aspirate [Wright-Giemsa (W-G), ×400]. (B) Hypocellular area was noted in the BM section [hematoxylin and eosin (H&E), ×100]. (C) The number of dysplastic megakaryocytes increased slightly in the cellular area (CD61 immunohistochemistry, ×400). (D) Hypocellular particles (W-G, ×40) are noted. (E) Severe hypocellular marrow is noted (H&E, ×40). (F) The hemophagocytic histiocytes are increased in the aspirate (W-G, ×400). (G) Megakaryocytes are normally observed in the aspirate (W-G, ×200). (H) Normocellular marrow for age (86 years) with a focally hypocellular area is noted (H&E, ×100).

Case 2

Fever and enlargement of the left inguinal lymph node developed in a 53-year-old man, and he was treated with antibiotics at a local hospital. However, pancytopenia was detected (Hb, 12.9 g/dL; white blood cell, 3.77×109/L; platelet, 24.0×109/L) at local hospital, and he was referred to our hospital for further evaluation and treatment. SFTSV was confirmed by RT-PCR analysis 5 at Division of Arboviruses, National Institute of Health, Korea Centers for Disease Control and Prevention. The laboratory and clinical findings at our hospital are summarized in Table 1 and 2. Severe hypocellular marrow was noted in an aspirate and section (Fig. 1D and E). Megakaryocytes were rarely found. He was treated with antibiotics; however, he died 10 days after admission due to multi-organ failure.

Case 3

An 86-year-old woman was admitted to our hospital for a 3 day fever. She had been with antibiotics at local hospital; however, pancytopenia was detected, and she was referred to our hospital for further evaluation and treatment. SFTSV was confirmed by RT-PCR analysis5 at Division of Arboviruses, National Institute of Health, Korea Centers for Disease Control and Prevention. The laboratory and clinical findings at our hospital are summarized in Table 1 and 2. Hemophagocytic histiocytes were observed in an aspirate (Fig. 1F). The megakaryocytes were normally observed in an aspirate (Fig. 1G). Normocellular marrow with focal hypocellular area was noted in the BM section (Fig. 1H). The patient was successfully treated with antibiotics and ribavirin.

DISCUSSION

Thrombocytopenia and leukopenia are prominent features in patients with SFTS. Viral replication in a mouse model mainly occurs in splenic macrophages.4 However, SFTSV is not found in mice BM,4 but the numbers of megakaryocytes increase in the spleen and BM of mice.4 In vitro cell assays show that SFTSV adheres to mouse platelets and facilitates phagocytosis of platelets by primary macrophages, suggesting that the cause of the thrombocytopenia is destruction by splenic macrophages.4 QuanTai, et al.2 compared the BM findings of five Chinese patients with SFTS with those of patients with aplastic anemia and normal healthy volunteers, and found no significant differences in cell morphology, cellularity, or numbers of megakaryocytes between them. They concluded that peripheral blood thrombocytopenia and leukopenia in patients with SFTS result from increased peripheral organ damage or circulating anti-platelet antibodies.2 However, hypocellular marrow with an increased number of hemophagocytic histiocytes is observed in Japanese patients with SFTS,3 whereas megakaryocytes are relatively preserved in BM.3 Consistent with these findings, our Korean patients also showed moderate to severe hypocellular marrow with an increased number of hemophagocytic histiocytes and/or relatively preserved megakaryocytes. The reason for the different BM findings between Chinese and Japanese or Korean patients with SFTS is unclear. The Chinese patients with SFTS were relatively young age (30–50 years) and all of them recovered successfully.2 However, our Korean patients with SFTS (53–86 years) and the Japanese patients with SFTS were older (>50 years), and two of our Korean patients died. Therefore, age and clinical status/severity may be the cause of the different BM findings.67 Deng, et al.8 also observed that two patients expired of SFTS presented with empty marrow. These two8 cases and our cases (case 1 and case 2) suggest that BM hypocellularity is associated with severity of SFTS. However, further studies are needed. Considering the results of animal experiments4 and those of pathological examinations of patients with SFTS,23 hemophagocytosis appears to be common in patients with SFTS, and the laboratory findings of most patients with SFTS are compatible with hemophagocytic lymphohistocytosis (fever, cytopenia, high ferritin level, etc.).79 Moreover, one study revealed that increased cytokine levels are correlated with viral load/clinical parameters in patients with SFTS.10 Since dysregulation of the immune system with hypercytokinemia is an underlying mechanism of hemophagocytic lymphohistocytosis,11 SFTSV may produce hemophagocytic lymphohistocytosis.9 Therefore, cytopenia in patients with SFTS may result from both peripheral destruction/sequestration and BM suppression. Based on the "cytokine storm" and "immune-mediated platelet consumption in the spleen" concepts, some authors have reported cases treated with plasmapheresis to reduce cytokine levels as well as other pathological immune-mediating agents.12 They reported two patients treated with ribavirin and plasmapheresis and they recovered from SFTS.12 However, plasmapheresis does not have demonstrated therapeutic efficacy until now. Our Patient 1 died after a plasmapheresis treatment. Therefore, further studies are needed to define the exact pathogenesis and the therapeutic implications. In conclusion, our results together with other studies indicate that BM suppression and hemophagocytic histiocytes are common findings in patients with SFTS. Although a limited number of cases were available, our observations may help understand the pathogenic mechanism of SFTSV and aid in future therapeutic applications.
  12 in total

1.  Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model.

Authors:  Cong Jin; Mifang Liang; Junyu Ning; Wen Gu; Hong Jiang; Wei Wu; Fushun Zhang; Chuan Li; Quanfu Zhang; Hua Zhu; Ting Chen; Ying Han; Weilun Zhang; Shuo Zhang; Qin Wang; Lina Sun; Qinzhi Liu; Jiandong Li; Tao Wang; Qiang Wei; Shiwen Wang; Ying Deng; Chuan Qin; Dexin Li
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

2.  Plasma exchange and ribavirin for rapidly progressive severe fever with thrombocytopenia syndrome.

Authors:  Won Sup Oh; Sang Taek Heo; Sun Hyung Kim; Won Jun Choi; Myung Guk Han; Ji Young Kim
Journal:  Int J Infect Dis       Date:  2013-10-02       Impact factor: 3.623

3.  Nosocomial transmission of severe fever with thrombocytopenia syndrome in Korea.

Authors:  Won Young Kim; WooYoung Choi; Sun-Whan Park; Eun Byeol Wang; Won-Ja Lee; Youngmee Jee; Kyoung Soo Lim; Hyun-Jung Lee; Sun-Mi Kim; Sang-Oh Lee; Sang-Ho Choi; Yang Soo Kim; Jun Hee Woo; Sung-Han Kim
Journal:  Clin Infect Dis       Date:  2015-02-18       Impact factor: 9.079

4.  Fever with thrombocytopenia associated with a novel bunyavirus in China.

Authors:  Xue-Jie Yu; Mi-Fang Liang; Shou-Yin Zhang; Yan Liu; Jian-Dong Li; Yu-Lan Sun; Lihong Zhang; Quan-Fu Zhang; Vsevolod L Popov; Chuan Li; Jing Qu; Qun Li; Yan-Ping Zhang; Rong Hai; Wei Wu; Qin Wang; Fa-Xian Zhan; Xian-Jun Wang; Biao Kan; Shi-Wen Wang; Kang-Lin Wan; Huai-Qi Jing; Jin-Xin Lu; Wen-Wu Yin; Hang Zhou; Xu-Hua Guan; Jia-Fa Liu; Zhen-Qiang Bi; Guo-Hua Liu; Jun Ren; Hua Wang; Zhuo Zhao; Jing-Dong Song; Jin-Rong He; Tao Wan; Jing-Shan Zhang; Xiu-Ping Fu; Li-Na Sun; Xiao-Ping Dong; Zi-Jian Feng; Wei-Zhong Yang; Tao Hong; Yu Zhang; David H Walker; Yu Wang; De-Xin Li
Journal:  N Engl J Med       Date:  2011-03-16       Impact factor: 91.245

Review 5.  Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: a journey of a thousand miles begins with a single (big) step.

Authors:  M B Jordan; A H Filipovich
Journal:  Bone Marrow Transplant       Date:  2008-08-04       Impact factor: 5.483

Review 6.  Advances in understanding the pathogenesis of HLH.

Authors:  G Naheed Usmani; Bruce A Woda; Peter E Newburger
Journal:  Br J Haematol       Date:  2013-04-12       Impact factor: 6.998

7.  Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients.

Authors:  Zhong-Tao Gai; Ying Zhang; Mi-Fang Liang; Cong Jin; Shuo Zhang; Cheng-Bao Zhu; Chuan Li; Xiao-Ying Li; Quan-Fu Zhang; Peng-Fei Bian; Li-Hua Zhang; Bin Wang; Na Zhou; Jin-Xia Liu; Xiu-Guang Song; Anqiang Xu; Zhen-Qiang Bi; Shi-Jun Chen; De-Xin Li
Journal:  J Infect Dis       Date:  2012-07-30       Impact factor: 5.226

8.  Age is a critical risk factor for severe fever with thrombocytopenia syndrome.

Authors:  Shujun Ding; Guoyu Niu; Xuehua Xu; Jinping Li; Xiaomei Zhang; Haiying Yin; Naijie Zhang; Xiaolin Jiang; Shiwen Wang; Mifang Liang; Xianjun Wang; Xue-jie Yu
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

9.  Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome Bunyavirus infection in Northeast China.

Authors:  Baocheng Deng; Bo Zhou; Shujun Zhang; Ying Zhu; Leqiang Han; Yingzhi Geng; Zhenan Jin; Hongbo Liu; Donglei Wang; Yitong Zhao; Ying Wen; Wei Cui; Ying Zhou; Qiuhong Gu; Cuiming Sun; Xu Lu; Wen Wang; Yu Wang; Chengbo Li; Yanli Wang; Wenqing Yao; Pei Liu
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

10.  The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan.

Authors:  Toru Takahashi; Ken Maeda; Tadaki Suzuki; Aki Ishido; Toru Shigeoka; Takayuki Tominaga; Toshiaki Kamei; Masahiro Honda; Daisuke Ninomiya; Takenori Sakai; Takanori Senba; Shozo Kaneyuki; Shota Sakaguchi; Akira Satoh; Takanori Hosokawa; Yojiro Kawabe; Shintaro Kurihara; Koichi Izumikawa; Shigeru Kohno; Taichi Azuma; Koichiro Suemori; Masaki Yasukawa; Tetsuya Mizutani; Tsutomu Omatsu; Yukie Katayama; Masaharu Miyahara; Masahito Ijuin; Kazuko Doi; Masaru Okuda; Kazunori Umeki; Tomoya Saito; Kazuko Fukushima; Kensuke Nakajima; Tomoki Yoshikawa; Hideki Tani; Shuetsu Fukushi; Aiko Fukuma; Momoko Ogata; Masayuki Shimojima; Noriko Nakajima; Noriyo Nagata; Harutaka Katano; Hitomi Fukumoto; Yuko Sato; Hideki Hasegawa; Takuya Yamagishi; Kazunori Oishi; Ichiro Kurane; Shigeru Morikawa; Masayuki Saijo
Journal:  J Infect Dis       Date:  2013-11-14       Impact factor: 5.226

View more
  2 in total

Review 1.  Systems Biology-Based Platforms to Accelerate Research of Emerging Infectious Diseases.

Authors:  Soo Jin Oh; Young Ki Choi; Ok Sarah Shin
Journal:  Yonsei Med J       Date:  2018-03       Impact factor: 2.759

2.  Application of the severe fever with thrombocytopenia syndrome prediction score: Differentiation of febrile diseases using basic laboratory parameters.

Authors:  Euijin Chang; Jeong-Han Kim; Ji Hwan Bang; Wan Beom Park; Eu Suk Kim; Sang Won Park; Myoung-Don Oh
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.